Kromek Share Discussion Threads

[charlie_bucket] 16/12/2021 16:59

Dear QuePassa, I suggest you finish reading your copy of Dummy’s Guide to Accounting & Finance in particular the chapter that teaches about group consolidation and the difference between group and company accounts. Or if it it’s not in there, read the more advanced books on your list so that you end up knowing what you’re talking about.

Kind regards, charlie_bucket (serious investor).

[quepassa] 16/12/2021 16:17

I guess the serious investor will be reading the accounts for themselves.

But anyone who fundamentally believes that a liquid cash deposit in a bank has the same characteristics and status as an intercompany receivable really does need to dust down their copy of a Dummy's Guide to Accounting and Finance.

Poor chaps.

[charlie_bucket] 16/12/2021 13:52

Quepassa, re your post 5658 re Kromek Ltd’s accounts. I answer here not because I particularly want to help you, but just in case others are confused or worried because of your alarmist words. As aqc888 says, you were told by others on the board a week or so ago that your point re the Kromek Ltd company accounts wasn’t valid and yet you persist…

I assume that you are still urging people to be worried about the large debtor and creditor balances on the balance sheet, particularly the £63m owed to Kromek Group plc. It's a non-issue.

Kromek LTD is a subsidiary of Kromek Group plc which is the ultimate parent company. It’s Kromek Group plc which is quoted on LSE and which received the cash from shareholders in the IPO and subsequent fundraisings from shareholders. But it’s Kromek Ltd and its subsidiaries (which includes the Kromek Inc. US legal entity) which spend a high proportion of the money. Kromek Group plc therefore needs to give a high proportion of the money that was raised to Kromek Ltd to spend, and does so by means of an intercompany loan which has grown over the years as more funds were raised and spent.

The size of that intercompany loan is of no consequence to shareholders, as it is eliminated (amounts owed and amounts owing cancel out) in the Kromek Group plc accounts. See for yourself, it’s not there in the group accounts (also filed at Companies House).

To illustrate if you're still confused: imagine a man owns a property which is debt-free. If he takes out a mortgage for £250k and puts the £250k cash in a bank account then he is not suddenly in financial distress. You certainly cannot only look at the mortgage and ignore the bank account, but must consolidate all positions together.

If that issue wasn't what you were concerned about and there was something else in the Kromek Ltd company accounts that you are concerned about that I might have missed, then do say.

[aqc888] 16/12/2021 11:52

You’d be entertaining, if you weren’t so predictable

[quepassa] 16/12/2021 10:40

You seem more manic and more anxious today.

And are clearly trying to provoke a fight for some irrational reason or other.

I recommend that you have a fight with the angry little man in the mirror. (ie yourself).

Such a poor chap.

[aqc888] 16/12/2021 10:27

My holding in Kromek is up 7.5% and will be significantly higher in the coming months.

Quepassa, you’re a bit like one of these characters movies who run out of ammunition and start throwing bottles or anything they can get their hands on in desperation.

You’ve made this point last week, I know it’s nonsense intended to scare, you know it’s nonsense, everybody knows it’s nonsense. But you keep saying because it’s all you’ve got.

[quepassa] 16/12/2021 10:11

AQ's idea of a great investment.


Kromek share price 24 months ago 27p. Today 15p.

I guess by his standards, this is good going.



However, for the serious investor, it is enlightening to look in detail at the latest accounts of Kromek Group's main operating subsiary, Kromek Limited, whose Annual Reports have recently been downloaded to Companies House.

ALL IMO. DYOR.
QP

[strategicinvestor2] 16/12/2021 09:57

A few weak holders selling missing the rise as usual. Very positive outlook here…IMHO looking to top up.

[aqc888] 16/12/2021 09:51

Quepassa, could you give me the names of some other shares you’re watching where the share price looks dire? You seem to have quite a reliable skill at this... your predictions with UPGS and Kromek were timed to perfection

[aqc888] 15/12/2021 17:11

Ark87, not sure why you’d describe Kromek having “Britain’;s foremost chemical weapons expert”- The Times, as a cheerleader of their biological pathogen detector, as a negative?

[aqc888] 15/12/2021 15:42

Ark87, could you provide an example of a complex product like this making it to market in a shorter timeframe? Serious question. I’m no expert in timeframes for developing new advanced technology such as this. Personally I think it’s pretty quick - if there’s positive news in January, as I hope, that would be less than 2years to speed up the development of it, raise the capital to develop it, start manufacturing it and gather orders and sales with governments. More importantly it’s within their time guidance they provided. Not sure what your complaint is?

[ark87] 15/12/2021 14:57

talk2tony - More waffle. Bretton-Gordon is KMK's cheerleader and trying to secure big orders via the media is desperate and shows negotiations have potentially broken down. Happy to be proven wrong but expecting in 2 months time from now still no updates. Time to forget about Covid detector and remain hopeful for other parts of the business to deliver.

[talk2tony] 15/12/2021 13:55

Continued ---- Effective detection would require an array of sensors — consisting of an air sampling device and a rapid DNA sequencer — at ports, airports, and international rail hubs. This would act as a virus weather map operating in near real time. Once detected, infected people or animals would be obliged to quarantine or isolate. Since the system picks up only the location of dangerous pathogens, rather than the individuals affected, people in the relevant area would have to agree to be tested in order to isolate the source. The cost of an integrated threat system is estimated at around £2bn for a country the size of the UK, according to the chemical, biological, radiological and nuclear threat security company Kromek. Given the £37bn budgeted for a moribund test and trace system, threat detection looks like good value.

The WHO, which is already responsible for pandemic surveillance, has had neither the resources nor the political clout to engineer change. But Johnson and his ministers should use the influence of Global Britain to lobby for investment in prevention worldwide. We have seen the damage done by the current pandemic: there is not a moment to waste in stopping the next in its tracks.

[talk2tony] 15/12/2021 13:33

Opinion Coronavirus pandemic ----

Covid has shown we must build better pandemic defences ----

Biological detection and surveillance systems would help find the next dangerous pathogen before it spreads -------

Hamish de Bretton-Gordon -------
The writer is biosecurity fellow at Magdalene College, Cambridge ------------------------

"The world has been struggling for nearly two years in the grip Covid-19, and the emergence of the Omicron variant has brought a wave of fresh infections. There is no doubt that the virus originated in China but that is as far as our knowledge goes: a serious lacuna given this pathogen has killed over 5.3m people and spread rapidly across the globe. The UK government has responded well with vaccines, therapeutic drugs and financial support to the economy. But it has done less well on procuring protective equipment, tracking the progression of the virus and working to detect the next pandemic.

This is despite intensifying calls for action. Microsoft co-founder Bill Gates last month urged the WHO to establish a task force for disease surveillance and suggested the US and UK would have to spend “tens of billions” on research and development to guard against a future pandemic. Sarah Gilbert, who led development of the AstraZeneca Covid vaccine, has also urged politicians to invest in prevention. “This will not be the last time a virus threatens our lives and our livelihoods,” she warned this month. “The truth is, the next one could be worse. It could be more contagious, or more lethal, or both.”

British ministers appear to recognise the importance of a pandemic threat infrastructure. Prime minister Boris Johnson spoke earlier this year of his ambitions for “an early warning system for the next pathogen, enabled by a worldwide network of pandemic surveillance centres”, and said the UK would work with the WHO on this project. However, progress updates have not been forthcoming. Britain’s Joint Biosecurity Centre, founded in May 2020 to advise government on outbreak response, could run an effective early detection force at a UK level. But its role is entirely reactive and focused on Covid-19: broadening its remit to detect and respond to the next pandemic would be a quick win.

National pathogen early warning systems (NPEWS) would help contain epidemics before they spread, and feed into a wider global system (GPEWS) to prevent epidemics progressing into full pandemics. A detection capacity in Wuhan might have prevented the reported 14m journeys in January 2020 which spread coronavirus worldwide before China finally locked down at the end of that month. Uncertainties around whether Covid originated as a leak from the Wuhan Institute of Virology make it imperative that all bio-safe labs where dangerous pathogens are examined should be fitted with systems which can immediately raise the alarm in case of any security breach.

[talk2tony] 15/12/2021 13:29

Looks like this could have given a boost today
Good to connect Kromek to UK export drive. Not forgetting Kromek is based in the north so a great sound bite for the levelling up agenda.

[aqc888] 15/12/2021 11:30

Agreed. Where the share price is heading is fairly predictable when looking at the chart and forthcoming news flow

[aqc888] 15/12/2021 09:56

You’ll see from my annoyingly frequent posts that I’ve been very closely watching Kromek. I have a feeling I will kick myself for only having 10% of my portfolio here

[aqc888] 15/12/2021 09:53

I’m aware you have no way of verifying this other than getting me to email screenshot to anyone who asks. But I put 15% of my portfolio in Duke Royalty last year. Mainly as I saw the investment case was outstanding, after much research.

But secondly, I had a high degree of certainty it would appear in the IC bargain shares edition, which it did. Not only that, but it’s one of the strongest performers last year.

I have the same conviction here.

[ali47fish] 15/12/2021 09:43

AQ I hope you become a visionary

[aqc888] 15/12/2021 09:41

I forecast the share price reaching 18p in the run up to the results. 26p upon news of biological pathogen detection sales (not included in any analyst forecasts). Then 35p following Kromeks appearance in Investors Chronicle Small cap bargain shares edition

[aqc888] 13/12/2021 17:04

Kromek - one of the few in positive territory today. Like a few posters on here said a while back, Kromek should act as a hedge in a market that takes another pandemic battering. The wind is in Kromeks sails. All segments set for growth. I believe this ‘strong buy’ favourite of Simon Thompson, at Investors Chronicle, will have a good chance in being in the Bargain shares 2022 edition in feb, which will skyrocket any other gains up to that point.

[quepassa] 11/12/2021 22:50

Talk about losing the plot.


More and more manic by the day.

Poor chap